Skip to main content

Kenya Explores Collaboration Opportunities in Vaccine Manufacturing with UAE-based Hayat Biotech

Nairobi, Kenya - 6th March 2024 - ย The CEO of Hayat Biotech UAE, Mr. Naser Al Yammhi, paid a courtesy call to the Principal Secretary for Medical Services, Harry Kimtai. Also present was the UAE Ambassador to Kenya, HE Dr. Salim Alnaqbi.

The discussion focused on potential collaboration between Hayat Biotech UAE and Kenya BioVax Institute in vaccine manufacturing and research within Kenya and the East African Community (EAC).

Dr. Michael Lusiola, the Managing Director/CEO of Kenya BioVax, also participated in the meeting.

The aim of the discussion was to forge a partnership and build capacity in vaccine production and research.